Artiva Biotherapeutics, Inc.
USD9.62
+0.79 (+8.95%)
CEO
Fred Aslan
IPO Date
2024-07-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$8.81
Prev. Close
$8.83
Day Low
$8.80
Day High
$9.66
52W Low
$1.48
52W High
$14.53
Market Cap
$0.24B
Volume
1.04M
| 15,414 |
| $8.99 |
| 16 Jun 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | P-Purchase | Acquired | 124,893 | $8.89 |
| 11 Jun 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | P-Purchase | Acquired | 479,039 | $6.91 |
| 11 Jun 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | P-Purchase | Acquired | 103 | $7.00 |
| 11 Jun 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | P-Purchase | Acquired | 548,580 | $7.91 |
| 28 May 2026 | GC Corp. | 10 percent owner | P-Purchase | Acquired | 1,085,069 | $11.52 |
| 28 May 2026 | GC Corp. | 10 percent owner | P-Purchase | Acquired | 347,222 | $11.52 |
| 19 May 2026 | Raymon Heather | SVP, Research and Development | S-Sale | Disposed | 3,095 | $9.01 |
| 19 May 2026 | Horan Christopher | Chief Tech Operations Officer | S-Sale | Disposed | 7,002 | $9.01 |